News & Blogs

Lonza’s Ibex Dedicate to Support the Commercial Manufacture of Kodiak’s KSI-301 – an Antibody Biopolymer Conjugate for Retinal Diseases

Kodiak Sciences, a clinical-stage biopharmaceutical company specializing in novel ophthalmic therapies, and Lonza announced today that the companies have signed a long-term contract for manufacturing KSI-301, an Antibody Biopolymer Conjugate (ABC) that is a potential first-line treatment for retinal vascular diseases.

August 10, 2020

Pilot Chemical Names Frank D. Nataro as North America Sales Manager

Pilot Chemical Company named Frank D. Nataro as the company’s new North America Sales Manager. Nataro will oversee all sales activities of the North American sales team and will be responsible for developing and executing sales strategy that delivers results in line with Pilot’s growth objectives.

August 4, 2020

Lonza’s Pharma Biotech Business Drives Strong H1 2020 Group Sales Growth and Margin Improvement

Lonza today reported strong Group sales growth of 7.7%3 and a resilient CORE EBITDA margin of 29.1%. The results reflect Lonza Group’s robustness to the challenges and uncertainties arising from the COVID-19 pandemic in H1.

July 24, 2020

SOCMA Applauds 3-Year Reauthorization of Chemical Facility Anti-Terrorism Standards

The Society of Chemical Manufacturers & Affiliates (SOCMA) today welcomes the passage of legislation that includes a 3-year reauthorization of the Department of Homeland Security’s (DHS) Chemical Facilities Anti-Terrorism Standards (CFATS).

July 20, 2020

New SOCMA Census Points to Strong Level of Business Confidence for Specialty Chemicals Supply Chain

The Society of Chemical Manufacturers & Affiliates (SOCMA) today released the findings of its inaugural industry census, which indicates specialty chemical companies remain bullish despite the uncertain landscape.

July 9, 2020

2020 Spring Regulatory Agendas

The federal agencies have released their Spring 2020 Regulatory Agendas, which contain agency-by-agency priorities and timelines for upcoming regulatory actions. SOCMA has reviewed the agendas and summarizes upcoming policy activities relevant to SOCMA members.

July 9, 2020

LATEST NEWS IN SPECIALTY CHEMICALS

Latest Updates

Lonza’s Ibex Dedicate to Support the Commercial Manufacture of Kodiak’s KSI-301 – an Antibody Biopolymer Conjugate for Retinal Diseases

Pilot Chemical Names Frank D. Nataro as North America Sales Manager

Lonza’s Pharma Biotech Business Drives Strong H1 2020 Group Sales Growth and Margin Improvement

SOCMA Applauds 3-Year Reauthorization of Chemical Facility Anti-Terrorism Standards

New SOCMA Census Points to Strong Level of Business Confidence for Specialty Chemicals Supply Chain

2020 Spring Regulatory Agendas

Paul Raymond Joins Monument Chemical as Chief Executive Officer

Sun Chemical and DIC Corporation Completes Acquisition of Digital Inks Business from Sensient Technologies Corporation

Pilot Chemical Launches New Surfactants to Help Formulators Meet New 1,4-Dioxane Regulations

Jack Bostock Named Chief Commercial Officer Of Chemvalon Business of InChem Group